Medicamen Biotech has informed that the Company has received Disclosures in terms of regulation 31(2) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 from Promoters for release of 16,61,200 shares pledged with Union Bank of India.
The above information is a part of company’s filings submitted to BSE.